SUNNYVALE, Calif., June 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated (Nasdaq: TOMO) by Accuray.
SUNNYVALE, Calif., May 19, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson , Ph.D., is scheduled to present at Jefferies' 2011 Global Healthcare
Company's Symposium Highlights Five-Year CyberKnife Prostate SBRT Outcomes, Demonstrates Treatment's Long-Term Efficacy SUNNYVALE, Calif. and WASHINGTON, May 16, 2011 /PRNewswire via COMTEX/ -- The American Urological Association (AUA) Meeting, May 16, 2011 -- Accuray Incorporated (Nasdaq: ARAY), a
This Recognition of Clinical Benefits Across Europe is Supported by Five-Year Outcomes for Low-Risk Prostate Cancer Patients Treated in Five Sessions SUNNYVALE, Calif., May 11, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery,
SUNNYVALE, Calif., May 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Securities and Exchange Commission has declared effective the company's Form S-4 Registration Statement relating to the
SUNNYVALE, Calif., May 5, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal year 2011, ended March 31, 2011 . For the third quarter of fiscal 2011, Accuray reported
SUNNYVALE, Calif., April 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in
SUNNYVALE, Calif., April 14, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its third quarter of fiscal 2011, ended March 31, 2011 on Thursday, May 5, 2011 after the market closes.
SUNNYVALE, Calif., March 28, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 10th Annual Needham Healthcare Conference in New York City on Tuesday, April 5, 2011 at
Combination of Two Best-in-Class Technologies Creates the Premier Radiation Oncology Company Acquisition Expected to be Accretive to Accuray's FY2013 Earnings SUNNYVALE, Calif. and MADISON, Wis., March 7, 2011 /PRNewswire via COMTEX/ -- Accuray (Nasdaq: ARAY), a global leader in the field of
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
